DGNMF.US Diagnamed Holdings Corp.

Healthcare Health Care Technology USA Stocks
0.0214 USD
Close of Nov 13, 2026
0.0180 0.1892
Market cap
USD 2.82M
P/E
-
P/B
14.62x
ROE
-
Dividend yield
-
Fundamental score
-

Ratios use the latest price and the current fiscal year annualized from 3 quarters up to Jun 2026.

Is DGNMF.US undervalued?

Graham number

The Graham number of Diagnamed Holdings Corp. cannot be estimated reliably (it needs positive earnings and book value).

Graham number = √(22.5 × EPS × book value per share): the most a defensive investor should pay according to Benjamin Graham. An estimate, not a recommendation to buy or sell. How is it calculated?

Diagnamed Holdings Corp. fundamental analysis

No fundamental analysis for Diagnamed Holdings Corp. yet.

Diagnamed Holdings Corp. stock price

Prices on the chart can differ slightly from the closing prices StockSummer uses for its ratios.

About Diagnamed Holdings Corp.

Diagnamed Holdings Corp. engages in the development and commercialization of AI healthcare solutions. The company focuses on developing BRAIN AGE BRAIN HEALTH, a brain health AI platform leveraging that aims to predict and monitor brain age and provide actionable insights for mental health and neurodegenerative disorders. It also engages in exploration of Colchester East Natural Hydrogen Project comprising of 2,104 claims located within the Cumberland Basin in Nova Scotia; a…

Full company profile